Asarina Pharma Company
.jpg)
Asarina Pharma is a Swedish biotech company developing Sepranolone for Allopregnanolone-related stress, compulsion, menstrual and neurological disorders.
.jpg)
Total Funding:
$24,828,814
Headquarters:
Solna, Stockholms Lan, Sweden
Funding Status:
IPO
Employee Number:
1-10
Estimated Revenue:
Less than $1M
Last Funding Type:
Post-IPO Equity
Last Funding Date:
2018-09-20
Investors Number:
4
Founded Date:
01-01-2006
Industry:
General Health Care